MT-ND2 and neuroblastoma: Darshit and Ramanathan showed that OGD exposure reduces ND2 expression in SH-SY5Y neuroblastoma cells, while GSK-3β inhibitor treatment restores ND2 expression and supports neuronal maintenance (Darshit & Ramanathan, 2016).